Thomas Joseph Tracy - 07 Mar 2025 SCHEDULE 13D Report for Transcode Therapeutics, Inc. Common Stock, par value $0.0001 per share (RNAZ)

Filing Manager: Thomas Joseph Tracy
Reporting Manager: Thomas Joseph Tracy
Security: Transcode Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: RNAZ
Shares outstanding: 700K shares
Disclosed Ownership: 35K shares
Ownership: 5%
Form type: SCHEDULE 13D
Filing time: 20 Mar 2025, 17:16:50 UTC
Date of event: 07 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Thomas Joseph Tracy	5%	35K	35K	0	/s/ Thomas Joseph Tracy	Thomas Joseph Tracy	0002062715